Publication Type : Journal Article
Publisher : National Library of medicine
Source : Dermatol Pract Concept. 2023 Jul 1;13(3):e2023127. doi: 10.5826/dpc.1303a127. PMID: 37557151; PMCID: PMC10412045.
Url : https://pubmed.ncbi.nlm.nih.gov/37557151/
Campus : Kochi
School : School of Medicine
Year : 2023
Abstract : Cutaneous immune-related adverse-events (cIRAEs), commonly seen in cancer patients receiving immune checkpoint inhibitors (ICI) are reported to be associated with better patient survival; however, they have seldom been studied in Indian population. Recent reports suggest racial differences in IRAEs and also in survival outcomes.
Cite this Research Publication : Duraisamy P, Panicker VV, Jose WM. Characterization and Prognostic Significance of Cutaneous Immune-Related Adverse Events in Indian Patients on Immune Checkpoint Inhibitor Therapy. Dermatol Pract Concept. 2023 Jul 1;13(3):e2023127. doi: 10.5826/dpc.1303a127. PMID: 37557151; PMCID: PMC10412045.